Teva Pharmaceuticals has recalled 130,514 bottles and bulk containers of Paliperidone, Fortamet (metformin), Metformin Hydrochloride, and Actoplus Met XR (pioglitazone/metformin) extended-release tablets. These medications are being recalled because some tablets may be missing a critical laser-drilled hole that is necessary for the drug to be released correctly into the body. This defect was identified across several different strengths and bottle sizes of these prescription medications sold throughout the United States.
The missing laser drilling on these extended-release tablets can prevent the medication from being released at the proper rate. This may result in the patient receiving too little of the medication or the drug not working as intended to manage their condition.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.